Get the Stockscreener App
1.13
2.59%
-0.03
Tenaya Therapeutics Inc stock is traded at $1.13, with a volume of 2.32M.
It is down -2.59% in the last 24 hours and up +32.83% over the past month.
Tenaya Therapeutics Inc is a preclinical stage biotechnology company focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease. It is advancing product candidates from three product platforms: gene therapy, cellular regeneration and precision medicine.
See More
Previous Close:
$1.16
Open:
$1.16
24h Volume:
2.32M
Relative Volume:
0.81
Market Cap:
$184.16M
Revenue:
-
Net Income/Loss:
$-111.13M
P/E Ratio:
-0.8561
EPS:
-1.32
Net Cash Flow:
$-91.53M
1W Performance:
-2.59%
1M Performance:
+32.83%
6M Performance:
+1.80%
1Y Performance:
-58.46%
1-Day Range:
$1.12
$1.21
1-Week Range:
$0.9005
$1.45
52-Week Range:
$0.36
$4.01
Tenaya Therapeutics Inc Stock (TNYA) Company Profile
Name
Tenaya Therapeutics Inc
Sector
Industry
Phone
415-865-2066
Address
171 OYSTER POINT BLVD., SUITE 500, SOUTH SAN FRANCISCO
Compare TNYA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TNYA
Tenaya Therapeutics Inc
|
1.13 | 205.35M | 0 | -111.13M | -91.53M | -1.32 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Tenaya Therapeutics Inc Stock (TNYA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-10-24 | Initiated | William Blair | Outperform |
| Nov-30-23 | Initiated | Leerink Partners | Outperform |
| Jun-15-22 | Initiated | H.C. Wainwright | Buy |
Tenaya Therapeutics Inc Stock (TNYA) Latest News
Tenaya: Two Heart Disorder Data Releases Q4 2025 Brings About Major Inflection Point - Seeking Alpha
Tenaya Therapeutics : Measuring Protein Expression in Cardiac Gene TherapyKOL Webcast Event Presentation (fea540) - MarketScreener
Tenaya Therapeutics Inc. stock momentum explainedTrade Risk Report & Daily Price Action Insights - Newser
Measuring Tenaya Therapeutics Inc.’s beta against major indices2025 Trade Ideas & Fast Entry Momentum Trade Alerts - Newser
What analysts say about Tenaya Therapeutics Inc. stock outlookJuly 2025 Outlook & Precise Trade Entry Recommendations - Newser
Volume spikes in Tenaya Therapeutics Inc. stock – what they meanJuly 2025 Reactions & Consistent Profit Trade Alerts - Newser
Long term hold vs stop loss in Tenaya Therapeutics Inc.July 2025 Market Mood & Momentum Based Trading Ideas - Newser
What technical models suggest about Tenaya Therapeutics Inc.’s comebackInsider Buying & Weekly Market Pulse Alerts - Newser
Tenaya therapeutics SVP, finance sells $3.7k in stock - Investing.com
Tenaya therapeutics SVP, finance sells $3.7k in stock By Investing.com - Investing.com UK
Tenaya therapeutics CMO Tingley sells $6.3k in shares - Investing.com
TNYA.O Soars 14.2%: What’s Driving the Surge in Tenaya Therapeutics? - AInvest
Tenaya Therapeutics’ Stocks Soar: Right Time to Buy? - StocksToTrade
TNYA.O Surges 11% Amid Clueless Technicals—What’s Really Moving This Biotech? - AInvest
Tenaya Therapeutics appoints new interim principal accounting officer - MSN
Is Tenaya Therapeutics Inc. forming a reversal patternWeekly Trend Recap & Real-Time Stock Entry Alerts - Newser
Will Tenaya Therapeutics Inc. see short term momentumMarket Risk Analysis & Risk Controlled Swing Alerts - Newser
Is this a good reentry point in Tenaya Therapeutics Inc.Risk Management & Daily Entry Point Alerts - Newser
How Resilient Is Tenaya Therapeutics Inc. Stock During Economic DownturnsJuly 2025 PreEarnings & Reliable Intraday Trade Alerts - Newser
Published on: 2025-08-17 18:15:07 - Newser
Recovery Signals Appearing in Tenaya Therapeutics Inc. ChartsMarket Movers & Expert Curated Trade Ideas - newsyoung.net
TNYA.O (Tenaya Therapeutics) Surges 22.5% — What’s Driving the Intraday Move? - AInvest
TNYA.O Spikes 22.5%: A Deep Dive into Technical, Order-Flow, and Peer Stock Clues - AInvest
Will earnings trigger a reversal in Tenaya Therapeutics Inc.July 2025 Final Week & High Accuracy Trade Signal Alerts - Newser
Why Tenaya Therapeutics Inc. is moving today2025 Momentum Check & Verified High Yield Trade Plans - Newser
Advanced analytics toolkit walkthrough for Tenaya Therapeutics Inc.2025 Technical Overview & High Accuracy Swing Entry Alerts - Newser
Understanding Tenaya Therapeutics Inc.’s price movementQuarterly Portfolio Review & Fast Exit and Entry Trade Guides - Newser
What institutions are buying Tenaya Therapeutics Inc. stock nowMarket Movers & High Accuracy Buy Signal Tips - Newser
How to read the order book for Tenaya Therapeutics Inc.New Guidance & Long-Term Safe Investment Plans - Newser
Individual Investors Are Tenaya Therapeutics, Inc.'s (NASDAQ:TNYA) Biggest Owners and Were Rewarded After Market Cap Rose by US$80m Last Week - 富途牛牛
Is Tenaya Therapeutics Inc. part of any major index2025 Top Decliners & Reliable Breakout Forecasts - mustnews.co.kr
Will Tenaya Therapeutics Inc. stock go up soonWeekly Market Report & Weekly Consistent Profit Watchlists - Newser
How sentiment analysis helps forecast Tenaya Therapeutics Inc.July 2025 Fed Impact & Real-Time Market Trend Scan - Newser
Short interest data insights for Tenaya Therapeutics Inc.GDP Growth & Weekly High Return Forecasts - Newser
Tenaya Therapeutics Skyrockets 18.8%—Can This Biotech Breakout Sustain Momentum? - AInvest
Tenaya Therapeutics Surges Forward: What’s Next? - StocksToTrade
Is Tenaya Therapeutics Inc. a defensive stockJuly 2025 EndofMonth & Fast Exit Strategy with Risk Control - newsyoung.net
Tenaya Therapeutics Reports Q2 2025 Financial Results - TipRanks
Elliott Wave Theory Predicts Pullback in Tenaya Therapeutics Inc.2025 Risk Factors & Momentum Based Trading Signals - thegnnews.com
Can Tenaya Therapeutics Inc. reach all time highs this yearTop Stocks for Quick Doubling - kangso.co.kr
What is Leerink Partnrs’ Estimate for TNYA FY2025 Earnings? - Defense World
Q3 EPS Estimate for Tenaya Therapeutics Lifted by Analyst - Defense World
Tenaya Therapeutics’ (TNYA) Buy Rating Reiterated at Chardan Capital - Defense World
Wall Street Zen Upgrades Tenaya Therapeutics (NASDAQ:TNYA) to Hold - Defense World
A Quick Look at Today's Ratings for Tenaya Therapeutics(TNYA.US), With a Forecast Between $3 to $5 - 富途牛牛
Tenaya Therapeutics to Participate in the Canaccord Genuity 45th Annual Growth Conference - GlobeNewswire
Heart Disease Cure? Tenaya CEO Reveals Latest Therapeutic Developments at Major Growth Conference - Stock Titan
Strong Financial Position and Promising Clinical Progress Drive Buy Rating for Tenaya Therapeutics - TipRanks
Tenaya Therapeutics shares rise 6.67% premarket after positive safety reviews for TN-201 and TN-401 gene therapy trials. - AInvest
Tenaya Therapeutics Posts Smaller Losses And Advances Gene Trials - Finimize
Tenaya (TNYA) Q2 Loss Narrows 59% - The Globe and Mail
Tenaya Therapeutics Inc Stock (TNYA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Tenaya Therapeutics Inc Stock (TNYA) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Tingley Whittemore | Chief Medical Officer |
Aug 18 '25 |
Sale |
1.25 |
5,053 |
6,331 |
172,803 |
| Ali Faraz | Chief Executive Officer |
Aug 18 '25 |
Sale |
1.25 |
14,533 |
18,210 |
302,792 |
0.94%
1.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):